130 related articles for article (PubMed ID: 37635363)
1. MITF E318K: A rare homozygous case with multiple primary melanoma.
Wallingford CK; Maas EJ; Howard A; DeBortoli E; Bhanja D; Lee K; Mothershaw A; Jagirdar K; Willett R; Betz-Stablein B; Sturm RA; Soyer HP; McInerney-Leo AM
Pigment Cell Melanoma Res; 2024 Jan; 37(1):68-73. PubMed ID: 37635363
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
Bonet C; Luciani F; Ottavi JF; Leclerc J; Jouenne FM; Boncompagni M; Bille K; Hofman V; Bossis G; Marco de Donatis G; Strub T; Cheli Y; Ohanna M; Luciano F; Marchetti S; Rocchi S; Birling MC; Avril MF; Poulalhon N; Luc T; Hofman P; Lacour JP; Davidson I; Bressac-de Paillerets B; Ballotti R; Marine JC; Bertolotto C
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376192
[TBL] [Abstract][Full Text] [Related]
5. Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation.
Bassoli S; Pellegrini C; Longo C; Di Nardo L; Farnetani F; Cesinaro AM; Pellacani G; Fargnoli MC
Melanoma Res; 2018 Apr; 28(2):166-169. PubMed ID: 29485552
[No Abstract] [Full Text] [Related]
6. Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.
Vergani E; Frigerio S; Dugo M; Devecchi A; Feltrin E; De Cecco L; Vallacchi V; Cossa M; Di Guardo L; Manoukian S; Peissel B; Ferrari A; Gallino G; Maurichi A; Rivoltini L; Sensi M; Rodolfo M
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573422
[TBL] [Abstract][Full Text] [Related]
7. The MC1R r allele does not increase melanoma risk in MITF E318K carriers.
Wallingford CK; Demeshko A; Krishnakripa AK; Smit DJ; Duffy DL; Betz-Stablein B; Pflugfelder A; Jagirdar K; Holland E; Mann GJ; Primiero CA; Yanes T; Malvehy J; Badenas C; Carrera C; Aguilera P; Olsen CM; Ward SV; Haass NK; Sturm RA; Puig S; Whiteman DC; Law MH; Cust AE; Potrony M; Soyer HP; McInerney-Leo AM
Br J Dermatol; 2023 May; 188(6):770-776. PubMed ID: 36879448
[TBL] [Abstract][Full Text] [Related]
8. Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients.
Ciccarese G; Dalmasso B; Bruno W; Queirolo P; Pastorino L; Andreotti V; Spagnolo F; Tanda E; Ponti G; Massone C; Drago F; Parodi A; Ghigliotti G; Pizzichetta MA; Ghiorzo P;
J Transl Med; 2020 Feb; 18(1):78. PubMed ID: 32054529
[TBL] [Abstract][Full Text] [Related]
9. Vulvar Melanoma in association with germline MITF p.E318K variant.
Koeller DR; Schwartz A; DeSimone MS; Rana HQ; Rojas-Rudilla V; Russell-Goldman E; Laga AC; Lindeman NI; Garber JE; Ghazani AA
Cancer Genet; 2022 Apr; 262-263():102-106. PubMed ID: 35220194
[TBL] [Abstract][Full Text] [Related]
10. The impact of MITF on melanoma development: news from bench and bedside.
Roider EM; Fisher DE
J Invest Dermatol; 2014 Jan; 134(1):16-17. PubMed ID: 24352080
[TBL] [Abstract][Full Text] [Related]
11. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
[TBL] [Abstract][Full Text] [Related]
12. MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors.
Berwick M; MacArthur J; Orlow I; Kanetsky P; Begg CB; Luo L; Reiner A; Sharma A; Armstrong BK; Kricker A; Cust AE; Marrett LD; Gruber SB; Anton-Culver H; Zanetti R; Rosso S; Gallagher RP; Dwyer T; Venn A; Busam K; From L; White K; Thomas NE;
Pigment Cell Melanoma Res; 2014 May; 27(3):485-8. PubMed ID: 24406078
[TBL] [Abstract][Full Text] [Related]
13. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Bertolotto C; Lesueur F; Giuliano S; Strub T; de Lichy M; Bille K; Dessen P; d'Hayer B; Mohamdi H; Remenieras A; Maubec E; de la Fouchardière A; Molinié V; Vabres P; Dalle S; Poulalhon N; Martin-Denavit T; Thomas L; Andry-Benzaquen P; Dupin N; Boitier F; Rossi A; Perrot JL; Labeille B; Robert C; Escudier B; Caron O; Brugières L; Saule S; Gardie B; Gad S; Richard S; Couturier J; Teh BT; Ghiorzo P; Pastorino L; Puig S; Badenas C; Olsson H; Ingvar C; Rouleau E; Lidereau R; Bahadoran P; Vielh P; Corda E; Blanché H; Zelenika D; Galan P; ; Aubin F; Bachollet B; Becuwe C; Berthet P; Bignon YJ; Bonadona V; Bonafe JL; Bonnet-Dupeyron MN; Cambazard F; Chevrant-Breton J; Coupier I; Dalac S; Demange L; d'Incan M; Dugast C; Faivre L; Vincent-Fétita L; Gauthier-Villars M; Gilbert B; Grange F; Grob JJ; Humbert P; Janin N; Joly P; Kerob D; Lasset C; Leroux D; Levang J; Limacher JM; Livideanu C; Longy M; Lortholary A; Stoppa-Lyonnet D; Mansard S; Mansuy L; Marrou K; Matéus C; Maugard C; Meyer N; Nogues C; Souteyrand P; Venat-Bouvet L; Zattara H; Chaudru V; Lenoir GM; Lathrop M; Davidson I; Avril MF; Demenais F; Ballotti R; Bressac-de Paillerets B
Nature; 2011 Oct; 480(7375):94-8. PubMed ID: 22012259
[TBL] [Abstract][Full Text] [Related]
14. The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian Patients.
Stoehr CG; Walter B; Denzinger S; Ghiorzo P; Sturm RA; Hinze R; Moch H; Junker K; Hartmann A; Stoehr R
Pathobiology; 2016; 83(4):165-9. PubMed ID: 26999813
[TBL] [Abstract][Full Text] [Related]
15. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
16. Cancer risks associated with the germline MITF(E318K) variant.
Guhan SM; Artomov M; McCormick S; Njauw C-; Stratigos AJ; Shannon K; Ellisen LW; Tsao H
Sci Rep; 2020 Oct; 10(1):17051. PubMed ID: 33051548
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study.
Gromowski T; Masojć B; Scott RJ; Cybulski C; Górski B; Kluźniak W; Paszkowska-Szczur K; Rozmiarek A; Dębniak B; Maleszka R; Kładny J; Lubiński J; Dębniak T
Cancer Genet; 2014 Apr; 207(4):128-32. PubMed ID: 24767713
[TBL] [Abstract][Full Text] [Related]
18. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Yokoyama S; Woods SL; Boyle GM; Aoude LG; MacGregor S; Zismann V; Gartside M; Cust AE; Haq R; Harland M; Taylor JC; Duffy DL; Holohan K; Dutton-Regester K; Palmer JM; Bonazzi V; Stark MS; Symmons J; Law MH; Schmidt C; Lanagan C; O'Connor L; Holland EA; Schmid H; Maskiell JA; Jetann J; Ferguson M; Jenkins MA; Kefford RF; Giles GG; Armstrong BK; Aitken JF; Hopper JL; Whiteman DC; Pharoah PD; Easton DF; Dunning AM; Newton-Bishop JA; Montgomery GW; Martin NG; Mann GJ; Bishop DT; Tsao H; Trent JM; Fisher DE; Hayward NK; Brown KM
Nature; 2011 Nov; 480(7375):99-103. PubMed ID: 22080950
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history.
Ghiorzo P; Pastorino L; Queirolo P; Bruno W; Tibiletti MG; Nasti S; Andreotti V; ; Paillerets BB; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2013 Mar; 26(2):259-62. PubMed ID: 23167872
[TBL] [Abstract][Full Text] [Related]
20. The MITF, p.E318K Variant, as a Risk Factor for Pheochromocytoma and Paraganglioma.
Castro-Vega LJ; Kiando SR; Burnichon N; Buffet A; Amar L; Simian C; Berdelou A; Galan P; Schlumberger M; Bouatia-Naji N; Favier J; Bressac-de Paillerets B; Gimenez-Roqueplo AP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4764-4768. PubMed ID: 27680874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
